1.
Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium.
2.
3.
Improved survival in patients with head and neck cancer treated in higher volume centres: A population-based study in Belgium.
4.
5.
6.
7.
EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians.
Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.